DAWN icon

Day One Biopharmaceuticals
DAWN

Overview Fund Activity

125 hedge funds and large institutions have $818M invested in Day One Biopharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 39 increasing their positions, 27 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
125
Holders Change
+17
Holders Change %
+15.74%
% of All Funds
2%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
34
Increased
39
Reduced
27
Closed
17
Calls
$1.35M
Puts
$394K
Net Calls
+$955K
Net Calls Change
+$2.41M

Top Buyers

1
B
Braidwell
Connecticut
$42.2M
2
Franklin Resources
Franklin Resources
California
$45.5M
3
NIP
Nicholas Investment Partners
California
$21.4M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
$7.53M
5
Goldman Sachs
Goldman Sachs
New York
$30.5M

Top Sellers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
$9.89M
2
PCM
Pathway Capital Management
California
$0
3
DM
Deerfield Management
New York
$0
4
Point72 Asset Management
Point72 Asset Management
Connecticut
$0
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$22.3M
Name Holding Trade Value Shares
Change 		Shares
Change %
Renaissance Technologies
26
Renaissance Technologies
New York
$5.07M +$3.1M +231,674 +157%
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$4.87M +$3.01M +225,451 +163%
Alyeska Investment Group
28
Alyeska Investment Group
Illinois
$3.55M +$1.63M +121,949 +85%
Bank of America
29
Bank of America
North Carolina
$3.12M +$1.46M +109,117 +88%
Squarepoint
30
Squarepoint
New York
$2.99M +$2.58M +193,161 +627%
Millennium Management
31
Millennium Management
New York
$2.94M +$2.94M +219,670 New
Northern Trust
32
Northern Trust
Illinois
$2.93M -$76.9K -5,748 -3%
Charles Schwab
33
Charles Schwab
California
$2.71M -$16.6K -1,238 -0.6%
SB
34
Samsara BioCapital
California
$2.63M – – –
Rafferty Asset Management
35
Rafferty Asset Management
New York
$2.56M -$187K -14,001 -7%
Morgan Stanley
36
Morgan Stanley
New York
$2.46M +$1.29M +96,654 +111%
CS
37
Candriam SCA
Luxembourg
$2.34M +$2.34M +190,193 New
CSS
38
Cubist Systematic Strategies
Connecticut
$2.31M +$1.72M +128,850 +296%
Norges Bank
39
Norges Bank
Norway
$2.26M +$816K +61,000 +56%
Deutsche Bank
40
Deutsche Bank
Germany
$2.25M +$2.03M +151,525 +901%
Two Sigma Investments
41
Two Sigma Investments
New York
$2.05M +$2.05M +153,569 New
Citigroup
42
Citigroup
New York
$2.05M +$842K +62,985 +70%
WP
43
Woodline Partners
California
$2.02M – – –
GPP
44
Great Point Partners
Connecticut
$1.89M -$5.39M -402,925 -74%
MAP
45
Moody Aldrich Partners
Massachusetts
$1.57M +$1.57M +117,326 New
Bank of New York Mellon
46
Bank of New York Mellon
New York
$1.49M +$149K +11,130 +11%
Macquarie Group
47
Macquarie Group
Australia
$1.47M – – –
SSA
48
Schonfeld Strategic Advisors
New York
$1.4M -$141K -10,560 -9%
Qube Research & Technologies (QRT)
49
Qube Research & Technologies (QRT)
United Kingdom
$1.39M +$1.22M +91,057 +686%
Susquehanna International Group
50
Susquehanna International Group
Pennsylvania
$1.35M +$1.08M +80,710 +392%
1
2
3 4 5